Attached files
| file | filename |
|---|---|
| S-1 - FORM S-1 - Phio Pharmaceuticals Corp. | b88518sv1.htm |
| EX-4.1 - EX-4.1 - Phio Pharmaceuticals Corp. | b88518exv4w1.htm |
| EX-3.2 - EX-3.2 - Phio Pharmaceuticals Corp. | b88518exv3w2.htm |
| EX-4.2 - EX-4.2 - Phio Pharmaceuticals Corp. | b88518exv4w2.htm |
| EX-99.2 - EX-99.2 - Phio Pharmaceuticals Corp. | b88518exv99w2.htm |
| EX-10.9 - EX-10.9 - Phio Pharmaceuticals Corp. | b88518exv10w9.htm |
| EX-10.5 - EX-10.5 - Phio Pharmaceuticals Corp. | b88518exv10w5.htm |
| EX-10.4 - EX-10.4 - Phio Pharmaceuticals Corp. | b88518exv10w4.htm |
| EX-10.3 - EX-10.3 - Phio Pharmaceuticals Corp. | b88518exv10w3.htm |
| EX-23.1 - EX-23.1 - Phio Pharmaceuticals Corp. | b88518exv23w1.htm |
| EX-99.1 - EX-99.1 - Phio Pharmaceuticals Corp. | b88518exv99w1.htm |
| EX-10.10 - EX-10.10 - Phio Pharmaceuticals Corp. | b88518exv10w10.htm |
Exhibit 10.11
June 9, 2011
Mr. Jeffery Solomon
Worcester Polytechnic Institute
100 Institute Road
Worcester, MA 01609-2280
Worcester Polytechnic Institute
100 Institute Road
Worcester, MA 01609-2280
Dear Mr. Solomon
This letter is to serve as an amendment to the Lease between RXi Pharmaceuticals Corporation and
Newgate Properties, LLC dated September 25, 2007 and later amended on August 28, 2008 and again on
January 23, 2009.
Landlord and Tenant agree to amend:
Section 1.1 as follows:
Premises: For the period from June 16, 2011 to June 30, 2012, the portion of the first floor of the
Building consisting of approximately 2,882 square feet of office space and a portion of the third
floor consisting of approximately 2,425 square feet of laboratory space, all as more particularly
shown on Exhibit A attached hereto. On or before June 15, 2011, Tenant agrees to vacant all other
third floor premises consisting of approximately 595 square feet of office space and approximately
850 square feet of laboratory space and Landlord agrees to give Tenant a rent credit of $2047.00
(1,445 x $34.00 / 12 x .5).
Basic Rent: Notwithstanding any verbal or written statements to the contrary, the Landlord and
Tenant hereby agree that the schedule of Basic Rent shall be:
1. For the period from July 1, 2011 to July 31, 2011 $15,036.50
2. For the period from August 1, 2011 to June 30, 2012 $16,363.25 per month
(Computed as 5,307 sf x $37.00 / 12 months)
2. For the period from August 1, 2011 to June 30, 2012 $16,363.25 per month
(Computed as 5,307 sf x $37.00 / 12 months)
Term: Notwithstanding any verbal or written statements to the contrary, the Landlord and Tenant
hereby agree that the Term of this Lease shall terminate on the earlier of:
1. June 30, 2012, or
2. 90 days from the date that Tenant provides written notice to Landlord of its intent to vacate the Premises and terminate the Lease.
2. 90 days from the date that Tenant provides written notice to Landlord of its intent to vacate the Premises and terminate the Lease.
[SIGNATURE PAGE FOLLOWS]
1
Tenant: |
||
/s/ Mark Ahn
|
June 10, 2011 |
|
Mark Ahn, Ph.D., President and CEO RXi Pharmaceuticals Corporation |
(Date) | |
Lessor: |
||
/s/ Jeffrey S. Solomon
|
6 /20/11 |
|
Jeffrey S. Solomon, EVP &CFO Worcester Polytechnic Institute |
(Date) |
2